Anavex Life Sciences Corp. (AVXL)
4.015
-0.10
(-2.31%)
USD |
NASDAQ |
Dec 12, 16:00
3.85
-0.16
(-4.11%)
After-Hours: 20:00
Anavex Life Sciences Cash and Short Term Investments (Quarterly): 102.58M for Sept. 30, 2025
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 293.75M |
| ADMA Biologics, Inc. | 61.38M |
| Aldeyra Therapeutics, Inc. | 75.30M |
| ACADIA Pharmaceuticals, Inc. | 847.02M |
| CorMedix, Inc. | 55.72M |